SCHEMBL887689

SCHEMBL887689

CCCCc1ccc(O)c(O)c1CCCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 3/20 0.58
▸ HTT P42858 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ ALOX5 P09917 6/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ELANE P08246 1/20 0.42
▸ CTSG P08311 1/20 0.42
▸ PRKCI P41743 1/20 0.41
▸ IAPP P10997 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5677866 0.96 TYR (0.64) TYRHTTNPC1HPGDMAPK1
SCHEMBL5195268 0.96 TYR (0.64) TYRHTTNPC1HPGDMAPK1
SCHEMBL5588171 0.94 TYR (0.66) TYRHTTALOX5MEN1TP53
SCHEMBL5676407 0.94 TYR (0.51) TYRHTTNPC1HPGDMAPK1
SCHEMBL5678426 0.94 TYR (0.52) TYRHTTNPC1HPGDMAPK1
SCHEMBL5590451 0.92 TYR (0.69) TYRHTTALOX5MEN1TP53
SCHEMBL5589521 0.92 TYR (0.69) TYRHTTALOX5MEN1TP53
SCHEMBL5588738 0.92 TYR (0.69) TYRHTTALOX5MEN1TP53
SCHEMBL1208346 0.92 TYR (0.69) TYRHTTALOX5MEN1TP53
SCHEMBL11698491 0.92 TYR (0.69) TYRHTTALOX5MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118079201-A Interventional therapy drug carrier and interventional therapy system 湖南埃普特医疗器械有限公司 2024-05-28 — — CN claimed
US-10202474-B2 Process for producing polydienes BRIDGESTONE CORPORATION (JP) 2019-02-12 — — US claimed
EP-3341386-A1 Platinum (II) Diene Complexes with Chelating Dianionic Ligands and their use in Hydrosilylation Reactions Momentive Performance Materials Inc. (US) 2018-07-04 — — EP claimed
US-20170073443-A1 PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (US) 2017-03-16 — — US claimed
WO-2017035171-A1 Platinum (II) Diene Complexes with Chelating Dianionic Ligands and their use in Hydrosilylation Reactions MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2017-03-02 — — WO claimed
US-20170057980-A1 Platinum (II) Diene Complexes with Chelating Dianionic Ligands and their use in Hydrosilylation Reactions MOMENTIVE PERFORMANCE MATERIALS INC. 2017-03-02 — — US claimed
CN-118079201-A Interventional therapy drug carrier and interventional therapy system 湖南埃普特医疗器械有限公司 2024-05-28 — — CN disclosed
CN-115428933-A Pepper sauce and preparation method thereof 四川川娃子食品有限公司 2022-12-06 — — CN disclosed
US-10451184-B2 Sliding member and method for producing same NISSAN MOTOR CO., LTD. (JP) 2019-10-22 — — US disclosed
EP-2949783-B1 SLIDING MEMBER AND METHOD FOR PRODUCING SAME NISSAN MOTOR (JP) 2019-10-09 — — EP disclosed
EP-1666573-B1 LOW-FRICTION SLIDING MECHANISM AND METHOD OF FRICTION REDUCTION NISSAN MOTOR (JP) 2019-05-15 — — EP disclosed
EP-1508611-B1 TRANSMISSION COMPRISING LOW-FRICTION SLIDING MEMBERS AND TRANSMISSION OIL THEREFOR NISSAN MOTOR (JP) 2019-04-17 — — EP disclosed
US-10202474-B2 Process for producing polydienes BRIDGESTONE CORPORATION (JP) 2019-02-12 — — US disclosed
EP-1508611-A2 Low-friction sliding member in transmission, and transmission oil therefor NISSAN MOTOR COMPANY, LIMITED (JP) 2005-02-23 — — EP disclosed
EP-1507070-A1 Fuel lubricated sliding mechanism Nissan Motor Co., Ltd. (JP) 2005-02-16 — — EP disclosed
CN-1580539-A Fuel lubricated sliding mechanism NISSAN MOTOR (JP) 2005-02-16 — — CN disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 — — WO disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 — — WO disclosed
US-5306591-A Higher mobility; improved development and transfer XEROX CORPORATION (US) 1994-04-26 — — US disclosed
US-4323714-A Alkylation of hydroxy-substituted aromatic compounds UOP INC. (US) 1982-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170057980-A1 Platinum (II) Diene Complexes with Chelating Dianionic Ligands and their use in Hydrosilylation Reactions PCNA, PDCD1LG2, HIRA TYR 4764/4885HTT 1164/4885NPC1 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback